Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Patton

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
RNA (New York, N.Y.)|December 16, 1998
Enhancer elements activate the weak 3' splice site of alpha-tropomyosin exon 2B T Dye, M Buvoli, S A Mayer, et al.
Clinical Genetics|June 17, 2008
Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer functionN Shariat, C D Holladay, R K Cleary, et al.
The Journal of Nursing Education|May 1, 1997
Enhancing the clinical practicum experience through journal writingJ G Patton, S J Woods, T Agarenzo, et al.
Molecular Biology of the Cell|August 22, 2001
Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactionsY Shav-Tal, M Cohen, S Lapter, et al.
Clinical Chemistry|November 1, 1983
Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of 125I-labeled low-density lipoproteins by combined use of two monoclonal antibodiesS J Mao, J G Patton, J J Badimon, et al.
The American Journal of Clinical Nutrition|April 1, 1986
Plasma lipids and apolipoprotein A-I and A-II levels in alcoholic patientsR D Hurt, E R Briones, K P Offord, et al.
Journal of Neuroscience Research|July 9, 1999
Identification of PSF, the polypyrimidine tract-binding protein-associated splicing factor, as a developmentally regulated neuronal proteinG Chanas-Sacré, C Mazy-Servais, R Wattiez, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
RNA (New York, N.Y.)|December 16, 1998
Enhancer elements activate the weak 3' splice site of alpha-tropomyosin exon 2B T Dye, M Buvoli, S A Mayer, et al.
Clinical Genetics|June 17, 2008
Isolated growth hormone deficiency type II caused by a point mutation that alters both splice site strength and splicing enhancer functionN Shariat, C D Holladay, R K Cleary, et al.
The Journal of Nursing Education|May 1, 1997
Enhancing the clinical practicum experience through journal writingJ G Patton, S J Woods, T Agarenzo, et al.
Molecular Biology of the Cell|August 22, 2001
Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactionsY Shav-Tal, M Cohen, S Lapter, et al.
Clinical Chemistry|November 1, 1983
Monoclonal antibodies to human plasma low-density lipoproteins. I. Enhanced binding of 125I-labeled low-density lipoproteins by combined use of two monoclonal antibodiesS J Mao, J G Patton, J J Badimon, et al.
The American Journal of Clinical Nutrition|April 1, 1986
Plasma lipids and apolipoprotein A-I and A-II levels in alcoholic patientsR D Hurt, E R Briones, K P Offord, et al.
Journal of Neuroscience Research|July 9, 1999
Identification of PSF, the polypyrimidine tract-binding protein-associated splicing factor, as a developmentally regulated neuronal proteinG Chanas-Sacré, C Mazy-Servais, R Wattiez, et al.
Pageof 4